Serum trough levels of infliximab are not associated with peripheral arthralgia activity in patients with inflammatory bowel disease

This study suggests that although therapeutic drug monitoring of infliximab can have a role in the management of Crohn's disease and ulcerative colitis, it does not seem to be useful in managing arthralgias associated with inflammatory bowel disease.